APA (7th ed.) Citation

R, T., KL, M., DG, T., A, K., HT, Q., VS, P., . . . C, C. (2026). Early syndecan-4 upregulation predicts cognitive and pathological trajectories in Alzheimer disease. Alzheimer's research & therapy, 18(1), . https://doi.org/10.1186/s13195-026-02043-2

Chicago Style (17th ed.) Citation

R, Tarawneh, et al. "Early Syndecan-4 Upregulation Predicts Cognitive and Pathological Trajectories in Alzheimer Disease." Alzheimer's Research & Therapy 18, no. 1 (2026). https://doi.org/10.1186/s13195-026-02043-2.

MLA (9th ed.) Citation

R, Tarawneh, et al. "Early Syndecan-4 Upregulation Predicts Cognitive and Pathological Trajectories in Alzheimer Disease." Alzheimer's Research & Therapy, vol. 18, no. 1, 2026, https://doi.org/10.1186/s13195-026-02043-2.